These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8338575)

  • 1. Elimination of ephedrine and pseudoephedrine cross-reactivity in the Coat-A-Count Methamphetamine radioimmunoassay.
    Spiehler VR; Maugh K; el Shami S
    J Anal Toxicol; 1993; 17(2):125-6. PubMed ID: 8338575
    [No Abstract]   [Full Text] [Related]  

  • 2. Elimination of interferences from ephedrine and related compounds in Coat-A-Count methamphetamine radioimmunoassay.
    Spiehler V; Wilson H; Pregger K; Harris R
    Clin Chem; 1993 Jan; 39(1):172-3. PubMed ID: 8380365
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine.
    D'Nicuola J; Jones R; Levine B; Smith ML
    J Anal Toxicol; 1992; 16(4):211-3. PubMed ID: 1501473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of a GC/MS artifact peak as methamphetamine.
    Hornbeck CL; Carrig JE; Czarny RJ
    J Anal Toxicol; 1993 Sep; 17(5):257-63. PubMed ID: 8107458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved determination of methamphetamine, ephedrine and methylephedrine in urine by extraction--thermospectrometry.
    Sakai T; Ohno N; hylephe
    Analyst; 1987 Feb; 112(2):149-52. PubMed ID: 3578821
    [No Abstract]   [Full Text] [Related]  

  • 6. False identification of urinary ephedrine as methamphetamine by gas chromatography/mass spectrometry with a DB-17 column.
    Takayasu T; Ohshima T; Ohtsuji M; Takayama N; Kondo T; Lin Z; Sato Y; Minamino T
    Nihon Hoigaku Zasshi; 1997 Jun; 51(3):235-40. PubMed ID: 9301231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.
    Stout PR; Klette KL; Horn CK
    J Forensic Sci; 2004 Jan; 49(1):160-4. PubMed ID: 14979364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine as an artifact of methamphetamine during periodate degradation of interfering ephedrine, pseudoephedrine, and phenylpropanolamine: an improved procedure for accurate quantitation of amphetamines in urine.
    Paul BD; Past MR; McKinley RM; Foreman JD; McWhorter LK; Snyder JJ
    J Anal Toxicol; 1994 Oct; 18(6):331-6. PubMed ID: 7823540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon coated magnetic nanoparticles as a novel magnetic solid phase extraction adsorbent for simultaneous extraction of methamphetamine and ephedrine from urine samples.
    Taghvimi A; Hamishehkar H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1041-1042():113-119. PubMed ID: 28033585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing sympathomimetic amines from amphetamine and methamphetamine in urine by gas chromatography/mass spectrometry.
    Thurman EM; Pedersen MJ; Stout RL; Martin T
    J Anal Toxicol; 1992; 16(1):19-27. PubMed ID: 1640694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A note on a simple estimation of amphetamine, methylamphetamine and ephedrine in horse urine.
    Karawya MS; El-Keiy MA; Wahba SK; Kozman AR
    J Pharm Pharmacol; 1968 Aug; 20(8):650-2. PubMed ID: 4386554
    [No Abstract]   [Full Text] [Related]  

  • 12. Simple HPLC method for detection of trace ephedrine and pseudoephedrine in high-purity methamphetamine.
    Makino Y
    Biomed Chromatogr; 2012 Mar; 26(3):327-30. PubMed ID: 21678457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of formation of methamphetamine-like artifacts by the monoacetates of pseudoephedrine and related compounds in the GC/MS analysis of urine extracts.
    Brooks KE; Smith NS
    J Anal Toxicol; 1993; 17(7):441-2. PubMed ID: 8309222
    [No Abstract]   [Full Text] [Related]  

  • 14. Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions.
    Cunningham JK; Liu LM
    Addiction; 2003 Sep; 98(9):1229-37. PubMed ID: 12930210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing over-the-counter ephedrine and pseudoephedrine products to prescription only: impacts on methamphetamine clandestine laboratory seizures.
    Cunningham JK; Callaghan RC; Tong D; Liu LM; Li HY; Lattyak WJ
    Drug Alcohol Depend; 2012 Nov; 126(1-2):55-64. PubMed ID: 22592141
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Bogun B; Moore S
    Forensic Sci Int; 2017 Sep; 278():68-77. PubMed ID: 28692860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2002 Mar; 67(60):14853-62. PubMed ID: 11922057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-positive RIA for methamphetamine following ingestion of an Ephedra-derived herbal product.
    Levisky JA; Karch SB; Bowerman DL; Jenkins WW; Johnson DG; Davies D
    J Anal Toxicol; 2003 Mar; 27(2):123-4. PubMed ID: 12670009
    [No Abstract]   [Full Text] [Related]  

  • 19. Profiling ephedrine/pseudoephedrine and methamphetamine synthesised from benzaldehyde, nitroethane and dimethyl carbonate.
    Miller BM; Carter JF; Cresswell SL; Loughlin WA; Culshaw PN
    Forensic Sci Int; 2024 Jul; 360():112063. PubMed ID: 38776711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of federal precursor chemical regulations on methamphetamine arrests.
    Cunningham JK; Liu LM
    Addiction; 2005 Apr; 100(4):479-88. PubMed ID: 15784062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.